Alyssa Johnson
Nurse Practitioner · Henderson, NCNPI 1124760137
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 25.7% of the total. Reporting peaked in 2024 at $543 and has fallen 55.0% since, to $244 in 2025.
Across 67 payments — averaging $19.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$337
- Novo Nordisk$304
- Aimmune Therapeutics, Inc.$82
- Lilly USA, LLC$78
- Pfizer$51
- AstraZeneca$49
- plus $409 from 16 others
What the payments were for
- Food & beverage$1,311100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $337 |
| Novo Nordisk | 12 | $304 |
| Aimmune Therapeutics, Inc. | 4 | $82 |
| Lilly USA, LLC | 4 | $78 |
| Pfizer | 3 | $51 |
| AstraZeneca | 4 | $49 |
| Corcept Therapeutics | 2 | $47 |
| GSK | 3 | $44 |
| Johnson & Johnson | 2 | $33 |
| Amgen | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Cardiovascular Systems Inc. | 1 | $27 |
| Teleflex LLC | 1 | $27 |
| Astellas Pharma US Inc | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Cequr Corporation | 2 | $20 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Gilead | 1 | $20 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Dexcom, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$125
How this compares
$1,311 in reported general payments places this provider in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 26 | $36,166 |
| MounjaroTirzepatide | 23 | $27,464 |
| JanuviaSitagliptin Phosphate | 28 | $24,411 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $18,589 |
| EliquisApixaban | 14 | $15,913 |
| JardianceEmpagliflozin | 14 | $10,411 |
| Fluticasone Propionate | 107 | $1,955 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $1,267 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 45 | $1,037 |
| Gabapentin | 47 | $873 |
| Atorvastatin Calcium | 107 | $852 |
| Hydroxyzine Hcl | 27 | $837 |
| Omeprazole | 45 | $678 |
| Rosuvastatin Calcium | 57 | $530 |
| Pantoprazole Sodium | 30 | $434 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $304 | $36,16626 claims |
| Lilly USA, LLCMounjaro | $78 | $27,46423 claims |
| MerckJanuvia | $18 | $24,41128 claims |
| GSKTrelegy Ellipta | $44 | $18,58921 claims |
| PfizerEliquis | $51 | $15,91314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in Henderson
- Sandrivette JohnsonRaleigh$573K
- Ayeshia WrightMocksville$145K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
- Mary DilorenzoCharlotte$71K
- Olivia OgburnWinston Salem$70K
- Bridget ArchambaultDurham$57K
- Deborah MayerChapel Hill$55K
- Amber SeilerGreensboro$55K
- Stephanie PascaleRaleigh$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.